Central Pharmaceuticals Ltd. Sustainability Profile
Central Pharmaceuticals Ltd., commonly referred to as Central Pharma, is a leading player in the pharmaceutical industry, headquartered in Bangladesh (BD). Established in 1996, the company has made significant strides in the production and distribution of high-quality medicines, primarily focusing on generic pharmaceuticals and over-the-counter products. With a strong operational presence across South Asia, Central Pharmaceuticals is renowned for its commitment to innovation and quality. The company offers a diverse range of core products, including antibiotics, analgesics, and cardiovascular medications, distinguished by their efficacy and affordability. Central Pharma has achieved notable market recognition, positioning itself as a trusted name in healthcare. Its dedication to research and development, alongside adherence to international quality standards, underscores its reputation as a reliable provider in the competitive pharmaceutical landscape.
DitchCarbon Score
How does Central Pharmaceuticals Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Central Pharmaceuticals Ltd.'s score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Central Pharmaceuticals Ltd.'s reported carbon emissions
Central Pharmaceuticals Ltd., headquartered in Bangladesh (BD), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges. In the context of the pharmaceutical industry, where sustainability and climate commitments are increasingly vital, Central Pharmaceuticals Ltd. may need to consider developing a comprehensive strategy to address carbon emissions and set measurable targets. This could involve aligning with industry standards and frameworks, such as the Science Based Targets initiative (SBTi), to enhance their climate commitments and improve transparency in their environmental impact. As of now, without specific emissions data or reduction initiatives, the company's climate strategy remains undefined, highlighting an opportunity for future development in sustainability practices.
How Carbon Intensive is Central Pharmaceuticals Ltd.'s Industry?
How Carbon Intensive is Central Pharmaceuticals Ltd.'s Location?
Central Pharmaceuticals Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Central Pharmaceuticals Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.